Japanese ICH M7 Workshop, 29 September 2014, Tokyo, Japan

On 29 September 2014, the Japan Pharmaceutical Manufacturers Association (JPMA) held a workshop on the ICH M7 Guideline on Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk.

This workshop aimed to provide a comprehensive introduction to the ICH M7 which had reached Step 4 as ICH harmonised tripartite Guideline. ICH M7 now enters the implementation step (Step 5).

The presentations in Japanese from the workshop are available on the JPMA website.

At a Glance...

29 September 2014 Tokyo, Japan